StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > SO DOES THIS MEAN MORE TESTING BEING DONE ?

<< Previous

Bullboard Posts

Next >>

Comment by brad129on May 16, 2023 11:01am

89 Views

Post# 35450286

RE:RE:SO DOES THIS MEAN MORE TESTING BEING DONE ?

IainCaimbeul wrote: "Scaled up..." and "...gaining traction" are basically meaningless generalisations.
Impossible to deduce anything of value, but just wait until q3 and then we will knock your socks off. Sure ya will James.

End of q3 so basically q4 which buys him a lot of time since reporting isn't until April 30 2024

<< Previous

Bullboard Posts

Next >>

Three micro-cap value stocks trading at peak pessimism